Business
– Synribo received provisional approval in 2012 subject to additional clinic trial data. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and Drug...
Hi, what are you looking for?
– Synribo received provisional approval in 2012 subject to additional clinic trial data. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and Drug...
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
– Takeda Israel Ltd. will be headquartered in the Tel Aviv area and will market products with an initial focus on oncology. – Takeda...
– More than 500, 000 new cases of cancer are diagnosed in Russia every year. – Lev Leviev / Photo Tamar Mutzafi – AFI...
– / By Niva Goldberg / One of the most difficult and stressful parts of Oncologists work with patients and their families, is talking...